What is the first line treatment for iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Iron Deficiency Anemia

The first-line treatment for iron deficiency anemia is oral iron supplementation, most commonly with ferrous sulfate 200 mg three times daily. 1

Oral Iron Therapy

  • Oral iron supplementation is the simplest, least expensive, and most effective approach to correct anemia and replenish iron stores 1
  • Ferrous sulfate 200 mg three times daily is the most commonly recommended formulation, though ferrous gluconate and ferrous fumarate are equally effective 1
  • Treatment should continue for three months after correction of anemia to adequately replenish iron stores 1
  • Expected response: Hemoglobin concentration should rise by approximately 2 g/dl after 3-4 weeks of treatment 1
  • Alternative formulations may be used if the standard tablet form is not tolerated:
    • Liquid preparations may be better tolerated by some patients 1
    • Adding ascorbic acid (vitamin C) enhances iron absorption and should be considered when response is poor 1

Monitoring and Follow-up

  • Hemoglobin concentration and red cell indices should be monitored at regular intervals 1
    • Recommended schedule: Every three months for one year, then after a further year 1
  • Additional oral iron should be given if hemoglobin or MCV falls below normal 1
  • Failure to respond to oral iron therapy may be due to:
    • Poor compliance
    • Misdiagnosis
    • Continued blood loss
    • Malabsorption 1

Special Considerations

Inflammatory Bowel Disease (IBD)

  • For patients with IBD and iron deficiency anemia:
    • Oral iron should be considered first-line for those with mild anemia, clinically inactive disease, and no previous intolerance to oral iron 1
    • Intravenous iron should be considered first-line for patients with:
      • Clinically active IBD
      • Previous intolerance to oral iron
      • Hemoglobin below 100 g/L
      • Need for erythropoiesis-stimulating agents 1

When to Consider Parenteral Iron

  • Parenteral iron should only be used when:
    • There is intolerance to at least two oral preparations
    • Non-compliance with oral therapy is an issue
    • Oral therapy is ineffective due to poor absorption
    • Rapid correction of anemia is required 1, 2
  • Drawbacks of parenteral iron include:
    • Pain with intramuscular administration
    • Higher cost
    • Risk of anaphylactic reactions 1
    • The rise in hemoglobin is generally no quicker than with oral preparations 1

Common Pitfalls and Caveats

  • Excessive dosing: Recent evidence suggests that lower doses (100 mg daily or every other day) may be as effective as traditional higher doses while causing fewer side effects 3, 2
  • Gastrointestinal side effects are common with oral iron and may reduce compliance 4
  • Failure to treat the underlying cause: While supplementing iron, it's essential to identify and address the source of iron loss or poor absorption 1
  • Inadequate duration of therapy: Treatment should continue for three months after normalization of hemoglobin to replenish iron stores 1
  • Overlooking inflammation: In patients with inflammatory conditions, serum ferritin up to 100 μg/L may still be consistent with iron deficiency 1

By following these guidelines for oral iron supplementation as first-line therapy for iron deficiency anemia, with appropriate monitoring and consideration of special circumstances, most patients will achieve resolution of their anemia and replenishment of iron stores.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Iron supplementation in iron deficiency anaemia].

Nederlands tijdschrift voor geneeskunde, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.